Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,519,446
-
Number of holders
-
374
-
Total 13F shares, excl. options
-
116,831,275
-
Shares change
-
-300,561
-
Total reported value, excl. options
-
$9,482,852,006
-
Value change
-
+$7,275,759
-
Put/Call ratio
-
183%
-
Number of buys
-
181
-
Number of sells
-
145
-
Price
-
$81.17
Institutional Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q1 2019
As of 31 Mar 2019 IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) had 374 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 116,831,275 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, Clearbridge Investments, LLC, BAILLIE GIFFORD & CO, BB BIOTECH AG, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, WADDELL & REED FINANCIAL INC, FIRST TRUST ADVISORS LP, and STATE STREET CORP.
This table shows 375 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.